November domestic pharma sales grow just 1% after strong show last month

Oct growth rate was 9.6%; Most big corporates saw volumes drop in November

After posting a strong growth in October, domestic pharma sales has once again slipped to a low single digit growth in November. From a 9.6 per cent growth in October, it has slowed down to one per cent growth in November even as major therapies continued to show positive growth. 

The overall market growth slowed down in November as the volume growth was in negative terrain, clocking a -6.9 per cent while price growth came in at 4.7 per cent and new introductions grew by 3.2 per cent. 

According to data from market research firm AIOCD AWACS, therapies like cardiac